135 related articles for article (PubMed ID: 3683690)
1. Minimal-change nephrotic syndrome in adults treated with alternate-day steroids.
Nair RB; Date A; Kirubakaran MG; Shastry JC
Nephron; 1987; 47(3):209-10. PubMed ID: 3683690
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
Li X; Li H; Chen J; He Q; Lv R; Lin W; Li Q; He X; Qu L; Suya W
Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults.
Fukudome K; Fujimoto S; Sato Y; Kitamura K
Nephrology (Carlton); 2012 Mar; 17(3):263-8. PubMed ID: 22117558
[TBL] [Abstract][Full Text] [Related]
4. Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children.
Donia AF; Gazareen SH; Ahmed HA; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
Nephrol Dial Transplant; 2003 Oct; 18(10):2054-8. PubMed ID: 13679480
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses.
Tse KC; Lam MF; Yip PS; Li FK; Choy BY; Lai KN; Chan TM
Nephrol Dial Transplant; 2003 Jul; 18(7):1316-20. PubMed ID: 12808168
[TBL] [Abstract][Full Text] [Related]
7. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
Shirai S; Imai N; Sueki S; Matsui K; Tominaga N; Sakurada T; Yasuda T; Kimura K; Shibagaki Y
Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
[TBL] [Abstract][Full Text] [Related]
8. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
Donia AF; Amer GM; Ahmed HA; Gazareen SH; Moustafa FE; Shoeib AA; Ismail AM; Khamis S; Sobh MA
Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
[TBL] [Abstract][Full Text] [Related]
9. Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults.
Takei T; Itabashi M; Moriyama T; Kojima C; Shiohira S; Shimizu A; Tsuruta Y; Ochi A; Amemiya N; Mochizuki T; Uchida K; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2013 May; 28(5):1225-32. PubMed ID: 23239834
[TBL] [Abstract][Full Text] [Related]
10. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
Waldman M; Crew RJ; Valeri A; Busch J; Stokes B; Markowitz G; D'Agati V; Appel G
Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
[TBL] [Abstract][Full Text] [Related]
12. [Combined effect of cyclosporin and prednisolone for minimal change nephrotic syndrome: comparison with prednisolone therapy].
Hayashi M; Kimura N; Fukatsu A
Nihon Jinzo Gakkai Shi; 2008; 50(5):581-7. PubMed ID: 18767486
[TBL] [Abstract][Full Text] [Related]
13. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.
Gilbert RD; Hulse E; Rigden S
Pediatr Nephrol; 2006 Nov; 21(11):1698-700. PubMed ID: 16932900
[TBL] [Abstract][Full Text] [Related]
14. Minimal change glomerular disease in Malaysian adults and use of alternate day steroid therapy.
Wang F; Looi LM; Chua CT
Q J Med; 1982; 51(203):312-28. PubMed ID: 7146313
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome.
Miyabe Y; Takei T; Iwabuchi Y; Moriyama T; Nitta K
Clin Exp Nephrol; 2016 Feb; 20(1):103-10. PubMed ID: 26138356
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
Kashtan C; Melvin T; Kim Y
Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697
[TBL] [Abstract][Full Text] [Related]
17. Natural history and response to treatment of minimal change nephrotic syndrome.
Prabhakar KS; Prakash KC; Mani MK
J Assoc Physicians India; 1993 May; 41(5):263-5. PubMed ID: 8300454
[TBL] [Abstract][Full Text] [Related]
18. [A case of high-age minimal change nephrotic syndrome relapse after 18-year remission and effective treatment with steroid and cyclosporin combined therapy].
Yoshimoto K; Wada T; Iwata Y; Sakai N; Shimizu M; Furuichi K; Yokoyama H; Kobayashi K
Nihon Jinzo Gakkai Shi; 2000 Oct; 42(8):640-3. PubMed ID: 11195400
[TBL] [Abstract][Full Text] [Related]
19. Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.
Ueda N; Kuno K; Ito S
Arch Dis Child; 1990 Oct; 65(10):1147-50. PubMed ID: 2248508
[TBL] [Abstract][Full Text] [Related]
20. [Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients].
Pruna A; Barka A; Nochy D; Hauet T; Boulanger H; Landais P
Nephrologie; 1997; 18(3):95-101. PubMed ID: 9297136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
